| Financial Year |
March 31 2023 |
| Monetary Funds |
23,471,392.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
500,000.00 |
| Accounts Receivable |
122,380,623.08 |
| Advances to Suppliers |
94,575,807.69 |
| Other Receivables |
32,064,459.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
312,918,479.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,066,568.81 |
| Other Current Assets |
26,921,111.21 |
| Total Current Assets |
619,898,441.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,615,319.23 |
| Long-term Equity Investment |
221,799,229.73 |
| Investment Properties |
19,111,335.85 |
| Fixed Assetes |
171,396,943.67 |
| Under-construction Projects |
3,364,025.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,351,126.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,035,418.24 |
| Deferred Income Tax Assets |
78,979,854.86 |
| Other Non-Current Assets |
124,778.76 |
| Sub-Total of Non-Current Assets |
546,134,430.95 |
| Total Assets |
1,166,032,872.62 |
| Short-Term Loans |
110,168,666.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
0.81 |
| Accounts Payable |
139,785,431.82 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,223,153.14 |
| Taxes Payable |
24,851,283.47 |
| Interest Payable |
-- |
| Dividend Payable |
10,969,594.62 |
| Other payables |
90,744,113.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
127,745,458.17 |
| Other Current Liabilities |
13,029,760.29 |
| Sub-Total of Current Liabilities |
631,456,335.42 |
| Long-term Loans |
36,441,813.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,334,788.77 |
| Deferred Income Tax Liabilities |
7,925,086.75 |
| Other Non-Current Liabilities |
53,000,000.00 |
| Sub-Total of Non-Current Liabilities |
137,327,208.18 |
| Total Liabilities |
768,783,543.60 |
| Paid-In Capital(Or Share Stock) |
448,200,000.00 |
| Capital Surplus |
90,880,238.17 |
| Surplus Reserve |
131,272,609.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-307,435,852.41 |
| Minority Stockholder's Interest |
36,313,066.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
360,936,262.80 |
| Owner's Equity（Stockholder's Equity） |
397,249,329.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,166,032,872.62 |
